NCT04458974

Brief Summary

Introduction Stroke is the main cause of disability in the world and its sequelae have a great impact in the functional independence and quality of life of patients and families. Unilateral spatial neglect is one of the most frequent cognitive deficits after stroke, and its maintenance is associated with poor functional outcome of the rehabilitation process. For many years clinical research has been conducted to develop new and effective rehabilitation strategies for neglect. Noninvasive brain stimulation (NIBS) techniques are important tools in this regard, and it should be considered as a therapeutic intervention used in combination with conventional neuropsychological approaches. Transcranial direct current stimulation (tDCS) is a noninvasive, safe, neurophysiological technique able to modulate cortical activity by inducing a weak electric current into the brain. The studies focused on neglect symptoms treatment by means of tDCS over the lesional and contralesional hemisphere have shown promising results and its combination with conventional neglect therapies may enhance treatment efficacy and speed the recovery. Objectives To improve neglect symptoms by reducing the pathological hyperactivity of the undamaged hemisphere after right medial cerebral artery stroke, through the application of multisite tDCS, and to validate a NIBS protocol for the enhancement of conventional neuropsychological rehabilitation outcome. Methods The sample will be composed by 30 patients with spatial neglect secondary to a ischemic stroke in the middle cerebral artery in subacute stage (3 to 12 months since the event). The patients will be randomly assigned to one experimental group (Active, Sham, and Control). The intervention protocol consists in a two weeks intervention (10 sessions, 45 min, Monday to Friday) of tDCS and neuropsychological rehabilitation applied concurrently. In each session a 20 min tDCS at 2 milliamps (m will be applied over P3 according to 10/20 EEG international system (cathodal) with return electrodes placed in C3,CP5,CP1,Pz,PO3,PO7,P7 (10/20 EEG). StarStim® tDCS 8 channels Multisite device will be used.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2019

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 12, 2019

Completed
8 months until next milestone

First Posted

Study publicly available on registry

July 7, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

November 9, 2022

Status Verified

November 1, 2022

Enrollment Period

4 years

First QC Date

November 12, 2019

Last Update Submit

November 8, 2022

Conditions

Keywords

neglectneuropsychological rehabilitationnon-invasive brain stimulationtranscranial direct current stimulationtDCSstroke

Outcome Measures

Primary Outcomes (8)

  • Change in hemispatial neglect symptomatology

    Change in hemispatial neglecteglect sympthomatology assessed by The Bell Test (Gauthier, Dehaut, and Joanette 1989)

    Pre and post intervention (3 days after the end of intervention)

  • Change in hemispatial neglect symptomatology

    Change in hemispatial neglecteglect sympthomatology assessed by Copy of drawings subtest Barcelona test (Peña Casanova 2005)

    Pre and post intervention (3 days after the end of intervention)

  • Change in hemispatial neglect symptomatology

    Change in hemispatial neglecteglect sympthomatology assessed by Line bisection test (Schenkenberg, Bradford, and Ajax 1980)

    Pre and post intervention (3 days after the end of intervention)

  • Change in hemispatial neglect symptomatology

    Change in hemispatial neglecteglect sympthomatology assessed by The motor-free visual perception test (MVPT): (Colarusso, Hammill, and Academic Therapy Publications 1995)

    Pre and post intervention (3 days after the end of intervention)

  • Change in functional independence

    Change in functional independence assessed by The Catherine Bergego Scale (Azouvi et al. 2003)

    Pre and post intervention (3 days after the end of intervention)

  • Change in functional independence

    Change in functional independence assessed by Barthel Index (Mahoney and Barthel 1965)

    Pre and post intervention (3 days after the end of intervention)

  • Change in general cognitive functioning

    Change in general cognitive functioning assessed by Mini-mental state examination (MMSE) (Folstein, Folstein, and McHugh 1975)

    Pre and post intervention (3 days after the end of intervention)

  • Change in neurophysiological assessment

    Change in neurophysiological assessment through a resting state EEG acquisition. EEG will be recorded at rest using 64 electrodes in a system 10-20 distribution. An actiCHamp amplifier (Brain Vision LLC, North Carolina, United States) will be used to amplify and digitize the EEG data at a sampling frequency of 512 Hz. Alpha, Beta, Theta and Gamma bands will be recorded.

    Pre and post intervention (3 days after the end of intervention)

Secondary Outcomes (1)

  • Side effects and patient comfort assessment

    Pre and post session (before and at the end of every session - 1 min after the end of the session)

Study Arms (3)

Experimental group (Exp)

EXPERIMENTAL

Active tDCS + conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation)

Device: Transcranial direct current stimulationProcedure: Neuropsychological rehabilitation

Sham-tDCS (Sham)

SHAM COMPARATOR

Sham tDCS + conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation

Device: Transcranial direct current stimulationProcedure: Neuropsychological rehabilitation

Control group (Control)

OTHER

Conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation) without tDCS.

Procedure: Neuropsychological rehabilitation

Interventions

The intervention consists in two-weeks treatment, 10 consecutive sessions of tDCS ( Monday to Friday) applied concurrently to neuropsychological rehabilitation. The tDCS Multisite StratStim® 8-channel device (Neuroelectrics) will be used for tDCS stimulation. The duration of the stimulation will be 20 minutes at 2 mA. The tDCS will be applied with the cathode positioned in P3 (following the international 10/20 EEG system), and the return electrodes will be placed in C3, CP5, CP1, Pz, PO3, PO7, P7. The sessions will last 1 hour.

Experimental group (Exp)Sham-tDCS (Sham)

The neuropsychological rehabilitation protocol has been designed for the recovery of neglect symptomatology. Each session will consist on the performance of different cognitive stimulation tasks aimed at improving attention and visoperceptive abilities. The tasks will be applied through the NeuronUp neurorehabilitation platform in order to achieve maximum homogeneity and objectivity across patients. The neuropsychological rehabilitation will last 30min (in 1h intervention session).

Control group (Control)Experimental group (Exp)Sham-tDCS (Sham)

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hemorrhagic or ischemic stroke in the right hemisphere.
  • Stroke 3 to 12 months since the event (regardless of whether or not they have received prior rehabilitation).
  • to 99 years-old.
  • Neuroimaging study.
  • Absence of previous strokes.
  • Functional capacity that allows him/her to remain seated and active for one hour (Barthel Index score greater than 5 in the item of transfers between chair and bed; this item can be scored from 0 to 15, being 0 totally dependent and 15 totally independent).
  • Right-handed manual dominance
  • Neglect scores on at least two of the three tests administered for the assessment of visuospatial neglect.
  • Signature of informed consent by the patient or his/her legal guardian.

You may not qualify if:

  • Dermatological problems (psoriasis, dermatitis on the scalp or face).
  • Presence of implants or metal parts in the head excluding fillings.
  • Pacemakers, medication pumps, stimulators (vagal, cerebral, transcutaneous), ventriculoperitoneal shunts or aneurysm clips.
  • Presence of previous strokes.
  • Severe cognitive impairment assessed using the Mini-mental state examination (MMSE), excluding patients with scores under 24 (the score of MMSE are between 0 and 30, being 0 severe cognitive impairment and 30 no cognitive impairment).
  • Significant language difficulties that not allow proper understanding of activities or severely limit expression.
  • History of alcohol or drug abuse.
  • Moderate or severe active depression.
  • Uncontrolled medical problems (pathologies in acute phase without medical or pharmacological treatment with proven efficacy or pathologies with imminent life risk).
  • Pregnancy or suspected pregnancy that will be checked by pregnancy test at the beginning of the study in patients of childbearing age and with the recommendation of the use of contraceptive methods until the end of the intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Beata María Ana (Brain Damage Unit)

Madrid, 28007, Spain

RECRUITING

MeSH Terms

Conditions

StrokePerceptual Disorders

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Central Study Contacts

Elena M Marron, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel, randomized, controlled and triple blind experimental study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 12, 2019

First Posted

July 7, 2020

Study Start

November 8, 2019

Primary Completion

November 1, 2023

Study Completion

November 1, 2023

Last Updated

November 9, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations